Show simple item record

dc.contributor.authorMiller, Michelle S.en_US
dc.contributor.authorSchmidt-Kittler, Olegen_US
dc.contributor.authorBolduc, David M.en_US
dc.contributor.authorBrower, Evan T.en_US
dc.contributor.authorChaves-Moreira, Danieleen_US
dc.contributor.authorAllaire, Marcen_US
dc.contributor.authorKinzler, Kenneth W.en_US
dc.contributor.authorJennings, Ian G.en_US
dc.contributor.authorThompson, Philip E.en_US
dc.contributor.authorCole, Philip A.en_US
dc.contributor.authorAmzel, L. Marioen_US
dc.contributor.authorVogelstein, Berten_US
dc.contributor.authorGabelli, Sandra B.en_US
dc.date.accessioned2014-10-01T14:29:03Z
dc.date.issued2014en_US
dc.identifier.citationMiller, M. S., O. Schmidt-Kittler, D. M. Bolduc, E. T. Brower, D. Chaves-Moreira, M. Allaire, K. W. Kinzler, et al. 2014. “Structural basis of nSH2 regulation and lipid binding in PI3Kα.” Oncotarget 5 (14): 5198-5208.en
dc.identifier.issn1949-2553en
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:12987346
dc.description.abstractWe report two crystal structures of the wild-type phosphatidylinositol 3-kinase α (PI3Kα) heterodimer refined to 2.9 Å and 3.4 Å resolution: the first as the free enzyme, the second in complex with the lipid substrate, diC4-PIP2, respectively. The first structure shows key interactions of the N-terminal SH2 domain (nSH2) and iSH2 with the activation loop that suggest a mechanism by which the enzyme is inhibited in its basal state. In the second structure, the lipid substrate binds in a positively charged pocket adjacent to the ATP-binding site, bordered by the P-loop, the activation loop and the iSH2 domain. An additional lipid-binding site was identified at the interface of the ABD, iSH2 and kinase domains. The ability of PI3Kα to bind an additional PIP2 molecule was confirmed in vitro by fluorescence quenching experiments. The crystal structures reveal key differences in the way the nSH2 domain interacts with wild-type p110α and with the oncogenic mutant p110αH1047R. Increased buried surface area and two unique salt-bridges observed only in the wild-type structure suggest tighter inhibition in the wild-type PI3Kα than in the oncogenic mutant. These differences may be partially responsible for the increased basal lipid kinase activity and increased membrane binding of the oncogenic mutant.en
dc.language.isoen_USen
dc.publisherImpact Journals LLCen
dc.relation.hasversionhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170646/pdf/en
dash.licenseLAAen_US
dc.subjectPIK3R1en
dc.subjectp85en
dc.subjectPIK3CAen
dc.subjectPI3Ken
dc.subjectPIPen
dc.titleStructural basis of nSH2 regulation and lipid binding in PI3Kαen
dc.typeJournal Articleen_US
dc.description.versionVersion of Recorden
dc.relation.journalOncotargeten
dash.depositing.authorBolduc, David M.en_US
dc.date.available2014-10-01T14:29:03Z
dc.identifier.doi10.18632/oncotarget.2263
dash.authorsorderedfalse
dash.contributor.affiliatedBolduc, David


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record